CN116531460A - 一种治疗巨大褥疮的中药散剂及其制备方法 - Google Patents
一种治疗巨大褥疮的中药散剂及其制备方法 Download PDFInfo
- Publication number
- CN116531460A CN116531460A CN202211100350.6A CN202211100350A CN116531460A CN 116531460 A CN116531460 A CN 116531460A CN 202211100350 A CN202211100350 A CN 202211100350A CN 116531460 A CN116531460 A CN 116531460A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- huge
- bedsores
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 46
- 208000004210 Pressure Ulcer Diseases 0.000 title claims abstract description 39
- 239000000843 powder Substances 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 18
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 18
- 244000153955 Reynoutria sachalinensis Species 0.000 claims abstract description 18
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 claims abstract description 18
- 241000270666 Testudines Species 0.000 claims abstract description 18
- 240000004824 Trimezia steyermarkii Species 0.000 claims abstract description 18
- 210000000988 bone and bone Anatomy 0.000 claims abstract description 18
- 229940116229 borneol Drugs 0.000 claims abstract description 18
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000003610 charcoal Substances 0.000 claims abstract description 18
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000009136 dragon's blood Substances 0.000 claims abstract description 18
- 241000972673 Phellodendron amurense Species 0.000 claims abstract description 17
- 235000008109 Thuja occidentalis Nutrition 0.000 claims abstract description 17
- 241001313857 Bletilla striata Species 0.000 claims abstract description 8
- 241000218636 Thuja Species 0.000 claims description 16
- 241000213006 Angelica dahurica Species 0.000 claims description 12
- 241001313855 Bletilla Species 0.000 claims description 10
- 238000001035 drying Methods 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 5
- 238000007873 sieving Methods 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 3
- 238000000643 oven drying Methods 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 2
- 238000012216 screening Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 22
- 230000035876 healing Effects 0.000 abstract description 9
- 230000001737 promoting effect Effects 0.000 abstract description 9
- 210000001519 tissue Anatomy 0.000 abstract description 9
- 208000025865 Ulcer Diseases 0.000 abstract description 4
- 231100000397 ulcer Toxicity 0.000 abstract description 4
- 206010053615 Thermal burn Diseases 0.000 abstract description 3
- 241000411851 herbal medicine Species 0.000 abstract description 3
- 230000017423 tissue regeneration Effects 0.000 abstract description 3
- 208000014674 injury Diseases 0.000 abstract description 2
- 230000008506 pathogenesis Effects 0.000 abstract description 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 2
- 230000008733 trauma Effects 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 abstract 3
- 240000003243 Thuja occidentalis Species 0.000 abstract 1
- 230000010261 cell growth Effects 0.000 abstract 1
- 210000002919 epithelial cell Anatomy 0.000 abstract 1
- 230000004089 microcirculation Effects 0.000 abstract 1
- 206010052428 Wound Diseases 0.000 description 47
- 208000027418 Wounds and injury Diseases 0.000 description 47
- 229940079593 drug Drugs 0.000 description 10
- 241000894006 Bacteria Species 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 230000001338 necrotic effect Effects 0.000 description 4
- 239000003973 paint Substances 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 208000006735 Periostitis Diseases 0.000 description 3
- 208000033809 Suppuration Diseases 0.000 description 3
- 235000019658 bitter taste Nutrition 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- 208000026106 cerebrovascular disease Diseases 0.000 description 3
- 238000001804 debridement Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 210000003460 periosteum Anatomy 0.000 description 3
- 208000024827 Alzheimer disease Diseases 0.000 description 2
- 208000010392 Bone Fractures Diseases 0.000 description 2
- 206010052770 Coma states Diseases 0.000 description 2
- 208000002249 Diabetes Complications Diseases 0.000 description 2
- 206010012655 Diabetic complications Diseases 0.000 description 2
- 206010017076 Fracture Diseases 0.000 description 2
- 206010033892 Paraplegia Diseases 0.000 description 2
- 206010039966 Senile dementia Diseases 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 235000019606 astringent taste Nutrition 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000001647 drug administration Methods 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- 208000031729 Bacteremia Diseases 0.000 description 1
- 208000003174 Brain Neoplasms Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 208000008924 Femoral Fractures Diseases 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical group O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 241000588915 Klebsiella aerogenes Species 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 240000002924 Platycladus orientalis Species 0.000 description 1
- 208000032536 Pseudomonas Infections Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 206010049514 Traumatic fracture Diseases 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940092559 enterobacter aerogenes Drugs 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 229960000282 metronidazole Drugs 0.000 description 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000004498 neuroglial cell Anatomy 0.000 description 1
- 230000024121 nodulation Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 235000019643 salty taste Nutrition 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 210000002303 tibia Anatomy 0.000 description 1
- 206010043827 tibia fracture Diseases 0.000 description 1
- 230000009772 tissue formation Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明涉及中药技术领域,具体涉及一种治疗巨大褥疮的中药散剂及其制备方法。中药散剂包括如下重量份数的组分:鳖甲50~60份,冰片20~30份,煅龙骨30~35份,虎杖25~30份,侧柏炭20~30份,白芨20~30份,血竭25~30份,白芷20~25份,黄柏25~35份。本发明根据褥疮的发病机理,结合多年使用经验,以清热解毒、散瘀止痛、生肌敛疮之功效的传统中草药组成复方,各味药材组分按比例进行配伍,组方合理,清热解毒,散瘀止痛,生肌敛疮,建立微循环,促进组织上皮细胞生长。针对巨大褥疮、烧烫伤和各种难治性溃疡以及外伤有显著治疗作用。
Description
技术领域
本发明涉及中药技术领域,具体涉及一种治疗巨大褥疮的中药散剂及其制备方法。
背景技术
随着人口老龄化逐年增多,并且呈现出加快增长的趋势,高龄老人、生活不能自理老年人、空巢老人数量庞大,老年病(糖尿病并发症、老年性骨折、老年痴呆症、脑血管病等)发病率高,因此出现行动不便、卧床老人增多,为此褥疮的发病率将随之增加。褥疮是由内因和外因引起的一种难治性复合性溃疡,临床上至今没有一种好的治疗方法,特别是巨大褥疮用保守疗法难以治愈,也是当今临床医学界的一大难题。褥疮的发病多为高位截瘫、脑血管病、外伤性骨折、糖尿病并发症、癌症晚期患者及伴有营养不良的老年痴呆患者。这类患者一旦发生褥疮,如不及时治疗创面将逐渐扩大导致继发性感染,引起全身反应的“菌血症”将危及生命,现有药物治疗效果不佳。
发明内容
针对现有药物对巨大褥疮治疗效果不佳的技术问题,本发明提供一种治疗巨大褥疮的中药散剂及其制备方法,对治疗巨大褥疮有显著疗效,创面愈合时间短,愈后不形成瘢痕组织,无任何毒副作用,使用安全,方便家庭用药。
第一方面,本发明提供一种治疗巨大褥疮的中药散剂,包括如下重量份数的组分:鳖甲50~60份,冰片20~30份,煅龙骨30~35份,虎杖25~30份,侧柏炭20~30份,白芨20~30份,血竭25~30份,白芷20~25份,黄柏25~35份。
进一步的,包括如下重量份数的组分:鳖甲52~58份,冰片22~28份,煅龙骨31~34份,虎杖26~29份,侧柏炭22~28份,白芨22~28份,血竭26~29份,白芷21~24份,黄柏27~33份。
进一步的,包括如下重量份数的组分:鳖甲55份,冰片25份,煅龙骨33份,虎杖28份,侧柏炭25份,白芨28份,血竭28份,白芷23份,黄柏30份。
进一步的,包括如下重量份数的组分:鳖甲50份,冰片20份,煅龙骨30份,虎杖25份,侧柏炭30份,白芨30份,血竭30份,白芷25份,黄柏35份。
进一步的,包括如下重量份数的组分:鳖甲60份,冰片30份,煅龙骨35份,虎杖30份,侧柏炭30份,白芨20份,血竭25份,白芷20份,黄柏25份。
第二方面,本发明提供一种治疗巨大褥疮的中药散剂的制备方法,包括如下步骤:将各组分分别炮制后按比例混合,炮制方法按新版药典规定的标准方法炮制,粉碎、过筛、烘干、灭菌后即得。
进一步的,过筛选择80目的筛网。
进一步的,烘干在烘干箱内进行,烘干温度65℃。
本发明各组分中:
煅龙骨:性微寒、味涩,具有平肝潜阳、生肌敛疮、镇静安神、收敛固涩等功效;本发明煅龙骨为君药。
鳖甲:性微寒、味咸具有滋阴潜阳、软坚散结、退热除蒸之功效。
冰片:性凉、味辛苦具有开窍醒神、清热止痛、可抑制中枢神经系统,表现为明显的镇静镇痛作用,有促进神经胶质细胞的生长和分裂、有抗炎、抗菌、祛腐消肿等功效;本发明组分中,鳖甲与冰片为臣药。
虎杖:性微寒、味微苦,具有活血化瘀、清热解毒止痛等功效。
白芨:性微寒、味苦甘、涩,具有收敛止血、消肿生肌等作用。
血竭:性平、味甘咸,具有止血定痛、活血化瘀、生肌敛疮等功效;本发明虎杖、白芨、血竭为佐药。
白芷:性温、味辛,具有散风除湿、通窍止痛、抗菌等功效。
黄柏:性寒、味苦,具有清热燥湿、泻火除烦、解毒疗疮等功效。
侧柏炭:性寒、味苦涩,具有凉血止血、化痰止咳、生发乌发的功效;本发明白芷、黄柏、侧柏炭为使药。
本发明以煅龙骨为君药,以鳖甲与冰片为臣药,以虎杖、白芨、血竭为佐药,以白芷、黄柏、侧柏炭为使药,根据褥疮的发病机理,结合多年使用经验,以清热解毒、散瘀止痛、生肌敛疮之功效的传统中草药组成复方,各味药材组分按比例进行配伍,组方合理,清热解毒,散瘀止痛,生肌敛疮,建立微循环,促进组织上皮细胞生长。针对巨大褥疮、烧烫伤和各种难治性溃疡以及外伤有显著治疗作用。
本发明的有益效果在于:
(1)本发明对巨大褥疮,以及烧烫伤和各种难治性溃疡等外伤有显著作用,创面愈合时间短,愈后不形成瘢痕组织,治愈率达98.5%,有效率100%;
(2)本发明组分中不含任何化工成分及激素,无毒副作用,工艺简单成本低,使用安全,方便家庭用药;
(3)本发明可以散剂的形式直接撒到创面内治疗,有效成分易于释放到腐烂的组织内吸收,药物直接进入病变组织能够充分发挥出药物的有效作用。
附图说明
为了更清楚地说明本发明实施例或现有技术中的技术方案,下面将对实施例或现有技术描述中所需要使用的附图作简单地介绍,显而易见地,对于本领域普通技术人员而言,在不付出创造性劳动的前提下,还可以根据这些附图获得其他的附图。
图1是本发明具体实施方式实施例1治疗过程中创面照片。
图2是本发明具体实施方式实施例3治疗过程中创面照片。
图3是本发明具体实施方式实施例4治疗过程中创面照片。
图4是本发明具体实施方式实施例5治疗过程中创面照片。
图5是本发明具体实施方式实施例6治疗过程中创面照片。
图6是本发明具体实施方式实施例7治疗过程中创面照片。
具体实施方式
为了使本技术领域的人员更好地理解本发明中的技术方案,下面将结合本发明实施例中的附图,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都应当属于本发明保护的范围。
如下实施例中药散剂均通过如下方法制备,将各组分分别炮制后按比例混合,炮制方法按新版药典规定的标准方法炮制,粉碎过80目筛,置于烘干箱内烘干,烘干温度65℃,灭菌3次后所得。
实施例1
一种治疗巨大褥疮的中药散剂,包括如下重量份数的组分:鳖甲55份,冰片25份,煅龙骨33份,虎杖28份,侧柏炭25份,白芨28份,血竭28份,白芷23份,黄柏30份。
病例一:某女性患者,因脑血管病合并外伤性股骨骨折卧床而出现巨大褥疮,用多种疗法治疗无效,创面感染逐渐扩大到16×13cm,深达骨膜,取坏死组织做细菌培养为产气肠杆菌感染,连续使用本实施例中药散剂3个月,见图1,其中1用药前创面照片,2为用药1个月创面照片,3为用药2个月创面照片,4为用药3个月创面照片,可以看出,病例一经用药治疗3个月后创面愈合。
实施例2
一种治疗巨大褥疮的中药散剂,包括如下重量份数的组分:鳖甲50份,冰片20份,煅龙骨30份,虎杖25份,侧柏炭30份,白芨30份,血竭30份,白芷25份,黄柏35份。
病例二:某女性患者,因糖尿病并发脑血栓出现偏瘫卧床9个月,骶尾骨处发生4级巨大褥疮,在家中用多种保守疗法治疗无效果。褥疮面积逐渐扩大到15×18cm深达骨膜。出现化脓性感染,当时病人体温达39.4℃处于昏迷状态,住院后医生给予清创处理,清出脓液及坏死组织约450毫升,取脓液做细菌培养为铜绿假单胞菌,血培养为同一种细菌生长,诊断为褥疮由铜绿假单胞菌感染引起的败血症。全身治疗根据药敏结果选择敏感的抗生素对症治疗,使用本实施例中药散剂创面治疗,每日两次暴露创面,用药第2天创面流出大量渗液,继续用药治疗第5天创面有明显好转疼痛减轻,渗液量减少肉芽组织开始生长,体温降到37.8℃,但病人未清醒仍处于浅昏迷状态,病人家属自动要求出院带药回家治疗。在家使用本实施例中药散剂治疗3个半月创面愈合,愈合后的组织平软弹性好并且与原来的皮肤颜色基本相同。未随访一年后无意得知病人痊愈,因此无中间治疗的照片。
实施例3
一种治疗巨大褥疮的中药散剂,包括如下重量份数的组分:鳖甲60份,冰片30份,煅龙骨35份,虎杖30份,侧柏炭30份,白芨20份,血竭25份,白芷20份,黄柏25份。
病例三:某女性患者。因患脑瘤手术后出现高位截瘫,卧床3个月在低尾骨处发生4级巨大褥疮,创面达16×16cm,深达骨膜,采用多种保守疗法治疗效果不佳,创面逐渐扩大并感染,体温达38.5℃。于2005年6月份清除创面内坏死组织,生理盐水500毫升加庆大霉素24万单位冲洗创面,创面内撒入本实施例提供的中药散剂,每日两次暴露创面,治疗2个月痊愈。如图2所示,1为清创前创面照片,2为清创后创面照片,3、4为治愈后创面照片,愈后创面部位组织平软有弹性并且与原来皮肤颜色基本一致。
实施例4
一种治疗巨大褥疮的中药散剂,包括如下重量份数的组分:鳖甲56份,冰片27份,煅龙骨33份,虎杖28份,侧柏炭22份,白芨28份,血竭29份,白芷23份,黄柏31份。
病例四:某男性患者,酒后切断左手小指,从第一关节处切掉两节,采用本实施例提供的中药散剂保守疗法治疗,用药治疗23天痊愈。如图3,1为治疗前创面照片,2为用药8天创面照片,3为用药16天创面照片,4为用药23天后治愈创面照片。
实施例5
一种治疗巨大褥疮的中药散剂,组分同实施例1。
病例五:某职工,因工作时机械挤压断裂伤左手中指,肌肉及指骨断掉,缝合治疗48天创面未愈合并且呈现感染化脓,指骨变黑坏死。使用本实施例提供中药散剂治疗42天痊愈,并且长出完整指甲及指纹。如图4,1为治疗前创面照片,2为用药第33天创面照片,3为用药48天后治愈创面照片。
实施例6
一种治疗巨大褥疮的中药散剂,组分同实施例1。
病例六:某女性患者,左腿胫骨骨折在当地中医院行钢板固定术,术后2个月余,刀口不愈合,胫骨外露,创面感染面积16×9cm,创面内有坏死物,四周红肿。清除坏死物,拆除线头6个,甲硝唑冲洗创面,使用本实施例中药散剂治疗3个月痊愈。如图5,1为治疗前创面照片,2为用药第11天创面照片,3为用药第75天创面照片,4为用药第90天创面照片。
实施例7
一种治疗巨大褥疮的中药散剂,组分同实施例1。
病例七:某男性职工,工作时电击伤左上肢,电烧伤面积15%,深Ⅲ°,用本实施例中药散剂治疗28天痊愈。如图6,1为治疗前创面照片,2为用药第18天创面照片,3为用药第28天创面照片。
尽管通过参考附图并结合优选实施例的方式对本发明进行了详细描述,但本发明并不限于此。在不脱离本发明的精神和实质的前提下,本领域普通技术人员可以对本发明的实施例进行各种等效的修改或替换,而这些修改或替换都应在本发明的涵盖范围内/任何熟悉本技术领域的技术人员在本发明揭露的技术范围内,可轻易想到变化或替换,都应涵盖在本发明的保护范围之内。
Claims (8)
1.一种治疗巨大褥疮的中药散剂,其特征在于,包括如下重量份数的组分:鳖甲50~60份,冰片20~30份,煅龙骨30~35份,虎杖25~30份,侧柏炭20~30份,白芨20~30份,血竭25~30份,白芷20~25份,黄柏25~35份。
2.如权利要求1所述的治疗巨大褥疮的中药散剂,其特征在于,包括如下重量份数的组分:鳖甲52~58份,冰片22~28份,煅龙骨31~34份,虎杖26~29份,侧柏炭22~28份,白芨22~28份,血竭26~29份,白芷21~24份,黄柏27~33份。
3.如权利要求1所述的治疗巨大褥疮的中药散剂,其特征在于,包括如下重量份数的组分:鳖甲55份,冰片25份,煅龙骨33份,虎杖28份,侧柏炭25份,白芨28份,血竭28份,白芷23份,黄柏30份。
4.如权利要求1所述的治疗巨大褥疮的中药散剂,其特征在于,包括如下重量份数的组分:鳖甲50份,冰片20份,煅龙骨30份,虎杖25份,侧柏炭30份,白芨30份,血竭30份,白芷25份,黄柏35份。
5.如权利要求1所述的治疗巨大褥疮的中药散剂,其特征在于,包括如下重量份数的组分:鳖甲60份,冰片30份,煅龙骨35份,虎杖30份,侧柏炭30份,白芨20份,血竭25份,白芷20份,黄柏25份。
6.一种权利要求1所述的治疗巨大褥疮的中药散剂的制备方法,其特征在于,包括如下步骤:将各组分分别炮制后按比例混合,粉碎、过筛、烘干、灭菌后即得。
7.如权利要求6所述的治疗巨大褥疮的中药散剂的制备方法,其特征在于,过筛选择80目的筛网。
8.如权利要求6所述的治疗巨大褥疮的中药散剂的制备方法,其特征在于,烘干在烘干箱内进行,烘干温度为65℃。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211100350.6A CN116531460A (zh) | 2022-09-09 | 2022-09-09 | 一种治疗巨大褥疮的中药散剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211100350.6A CN116531460A (zh) | 2022-09-09 | 2022-09-09 | 一种治疗巨大褥疮的中药散剂及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116531460A true CN116531460A (zh) | 2023-08-04 |
Family
ID=87456593
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211100350.6A Pending CN116531460A (zh) | 2022-09-09 | 2022-09-09 | 一种治疗巨大褥疮的中药散剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116531460A (zh) |
-
2022
- 2022-09-09 CN CN202211100350.6A patent/CN116531460A/zh active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3466447A1 (en) | Topical pharmaceutical composition for treating multiple forms of skin wounds and manufacturing method thereof | |
CN101543565B (zh) | 一种治疗外科伤口感染的中药外用制剂药品及制造方法 | |
CN101310748A (zh) | 一种治疗烧烫伤的软膏 | |
CN106581439A (zh) | 一种治疗创伤、糖尿病足和皮肤溃烂的中药组合物及其制备方法 | |
CN103893557A (zh) | 一种治疗褥疮的中药制剂 | |
CN103845578B (zh) | 治疗烧烫伤、褥疮、带状疱疹外用酊剂及制备方法 | |
CN107982387A (zh) | 一种治疗烫伤的中药组合物及其制备方法 | |
CN105250712B (zh) | 一种治疗褥疮的中药组合物 | |
CN113262264A (zh) | 一种用于止痛生肌的中药组合物及其制备方法 | |
CN116531460A (zh) | 一种治疗巨大褥疮的中药散剂及其制备方法 | |
CN111991471A (zh) | 一种治疗刀伤、创伤、烧烫伤的外用中药制剂及其制备方法 | |
CN105726962A (zh) | 一种促进伤口愈合的中药组合物及其制备方法 | |
CN1172700C (zh) | 治疗烧伤外用药物及其制备方法 | |
CN102284006B (zh) | 一种治疗褥疮及烧烫创伤的外用膏剂 | |
CN104997918A (zh) | 一种治疗脚癣的中药组合物 | |
CN104958757A (zh) | 压疮膏及压疮膏的制备方法 | |
CN104623304A (zh) | 一种治疗湿热毒蕴型慢性皮肤溃疡的洗剂及其制备方法 | |
CN104306707A (zh) | 一种治疗褥疮的药物组合物 | |
CN109745429A (zh) | 一种治疗外伤久不愈合的中药及其制备方法 | |
CN109045204A (zh) | 一种治疗烧伤和烫伤的中药液及其制备方法 | |
CN108653588A (zh) | 一种治疗骨科疾病的外敷中药 | |
CN108785530A (zh) | 一种液化生肌愈皮膏及其制备方法 | |
CN105596766A (zh) | 一种褥疮护理中药药膏及其制备方法 | |
CN116898932A (zh) | 一种外用创伤药及制备方法 | |
CN115300562A (zh) | 一种治疗糖尿病足的生肌膏及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |